2017
DOI: 10.1039/c7md90004j
|View full text |Cite
|
Sign up to set email alerts
|

Correction: Boron-containing delocalised lipophilic cations for the selective targeting of cancer cells

Abstract: Correction for “Boron-containing delocalised lipophilic cations for the selective targeting of cancer cells” by Gianpiero Calabrese et al., Med. Chem. Commun., 2017, 8, 67–72.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
7
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…This, along with its hydrophobicity and electron withdrawing properties through the carbon cluster, Cc, [35][36][37] suggests the possibility of inducing distinct geometrical behaviour in boron rich macromolecules or particles of significance for Boron Neutron Capture Therapy (BNCT), [38][39][40][41][42][43][44] an alternative radiotherapy used for aggressive and infiltrating types of cancer that can not be treated with surgery or standard radio or chemotherapy, and by drug delivery. 45,46 The theoretical advantage of BNCT is that it can selectively destroy tumour cells infiltrating normal tissue with the requirement that sufficient amounts of 10 B and thermal neutrons are properly delivered to the site of the tumour. [38][39][40][41][42][43][44][45][46] Clinical interest in BNCT has focused primarily on high grade gliomas and on recurrent tumours of the head and neck region who have failed conventional therapy.…”
Section: Introductionmentioning
confidence: 99%
“…This, along with its hydrophobicity and electron withdrawing properties through the carbon cluster, Cc, [35][36][37] suggests the possibility of inducing distinct geometrical behaviour in boron rich macromolecules or particles of significance for Boron Neutron Capture Therapy (BNCT), [38][39][40][41][42][43][44] an alternative radiotherapy used for aggressive and infiltrating types of cancer that can not be treated with surgery or standard radio or chemotherapy, and by drug delivery. 45,46 The theoretical advantage of BNCT is that it can selectively destroy tumour cells infiltrating normal tissue with the requirement that sufficient amounts of 10 B and thermal neutrons are properly delivered to the site of the tumour. [38][39][40][41][42][43][44][45][46] Clinical interest in BNCT has focused primarily on high grade gliomas and on recurrent tumours of the head and neck region who have failed conventional therapy.…”
Section: Introductionmentioning
confidence: 99%
“…1) are known to accumulate selectively in the mitochondria of cancerous cells. [1][2][3] This is attributed to the elevated mitochondrial membrane potential present in a broad range of cancer cells compared to healthy epithelial cells (ca. 60 mV e.g.…”
mentioning
confidence: 99%
“…−163 mV in colon carcinoma cells vs. −104 mV in kidney epithelial cells). 2,4 Very high tumour to normal tissue uptake ratios (ca. 40 : 1) have been obtained in vivo for 1 and 2.…”
mentioning
confidence: 99%
See 2 more Smart Citations